Auris Medical (EARS) Stock Price, News & Analysis

Company Overview

Auris Medical Holding Ltd. engages in the development of novel products that address unmet medical needs in neurology and central nervous system disorders. It operates through Switzerland and Australia geographical segments. Its product pipeline includes AM-125, AM-201, AM301, Sonsuvi, and Keyzilen. The company was founded by Thomas Meyer in April 2003 and is headquartered in Hamilton, Bermuda.

Key Stats

• Today's Range: N/A
• 50-Day Range: $2.25 to $3.27
• 52-Week Range: N/A
• Volume: 830,271 shs
• Average Volume: 3.10 million shs
• Market Capitalization: $3.43 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

EARS Stock Analysis - Frequently Asked Questions

How were Auris Medical's earnings last quarter?

Auris Medical Holding Ltd. (NASDAQ:EARS) released its quarterly earnings data on Thursday, May, 11th. The biotechnology company reported ($4.40) earnings per share for the quarter, missing analysts' consensus estimates of ($2.80) by $1.60.

When did Auris Medical's stock split?

Auris Medical shares reverse split on the morning of Wednesday, May 1st 2019.The 1-20 reverse split was announced on Tuesday, April 30th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, April 30th 2019. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Auris Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Auris Medical investors own include Helios and Matheson Analytics (HMNY), TransEnterix (TRXDW), Novavax (NVAX), OPKO Health (OPK), Anavex Life Sciences (AVXL), Flexion Therapeutics (FLXN) and Rigel Pharmaceuticals (RIGL).

Company Calendar

• Last Earnings: 5/11/2017
• Today: 8/10/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical Preparations
• Sub-Industry: N/A
• Current Symbol: NASDAQ:EARS
• CIK: 1601936
• Web: www.aurismedical.com
• Phone: (441) 295-5950
• Fax: N/A
• Employees: 132,200
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 3.83
• Quick Ratio: 3.83

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.57 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 11,417,000
• Free Float: N/A
• Market Cap: $3.43 million
• Optionable: Not Optionable
• Beta: 1.17